histidinol has been researched along with fluorouracil in 8 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 7 (87.50) | 18.7374 |
1990's | 1 (12.50) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Martin, DS; Stolfi, RL | 1 |
Martin, DS; Sawyer, RC; Stolfi, RL | 2 |
Cheng, I; Fang, WD; Warrington, RC | 1 |
Edelstein, MB; Heilbrun, LK | 1 |
Fang, WD; Warrington, RC | 2 |
Fang, WD; Muzyka, TG; Warrington, RC | 1 |
8 other study(ies) available for histidinol and fluorouracil
Article | Year |
---|---|
Chemotherapeutic activity of L-histidinol against spontaneous, autochthonous murine breast tumors.
Topics: Animals; DNA, Neoplasm; Female; Fluorouracil; Histidinol; Mammary Neoplasms, Animal; Mice; RNA, Neoplasm | 1990 |
Effect of L-histidinol on the metabolism of 5-fluorouracil in the BALB/c x DBA/8 F1 murine tumor system.
Topics: Animals; DNA, Neoplasm; Fluorouracil; Histidinol; Imidazoles; Mice; Mice, Inbred BALB C; Mice, Inbred DBA; Neoplasms, Experimental; Phosphoribosyl Pyrophosphate; RNA, Neoplasm; Uracil Nucleotides | 1988 |
Effects of L-histidinol on the susceptibility of P815 mastocytoma cells to selected anticancer drugs in vitro and in DBA/2J mice.
Topics: Animals; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Cell Cycle; Cell Survival; Cytarabine; Dose-Response Relationship, Drug; Female; Flow Cytometry; Fluorouracil; Histidinol; Imidazoles; Mast-Cell Sarcoma; Mice; Mice, Inbred DBA; Neoplastic Stem Cells; Peritoneal Neoplasms | 1987 |
Specificity, schedule, and proliferation dependence of infused L-histidinol after 5-fluorouracil in mice.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Cell Division; Dose-Response Relationship, Drug; Drug Administration Schedule; Fluorouracil; Hematopoietic Stem Cells; Histidinol; Imidazoles; Mice; Mice, Inbred BALB C; Mice, Inbred DBA | 1988 |
Failure of L-histidinol to improve the therapeutic efficiency of 5-fluorouracil against murine breast tumors.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Aspartic Acid; Cell Cycle; Female; Fluorouracil; Histidinol; Imidazoles; Lethal Dose 50; Leukemia L1210; Mammary Neoplasms, Experimental; Mice; Mice, Inbred Strains; Phosphonoacetic Acid | 1987 |
Histidinol-mediated enhancement of the specificity of two anticancer drugs in mice bearing leukemic bone marrow disease.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Colony-Forming Units Assay; Cytarabine; Drug Synergism; Femoral Neoplasms; Flow Cytometry; Fluorouracil; Histidinol; Imidazoles; Leukemia L1210; Mice; Mice, Inbred DBA; Time Factors | 1985 |
Histidinol-mediated improvement in the specificity of 1-beta-D-arabinofuranosylcytosine and 5-fluorouracil in L 1210 leukemia-bearing mice.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Cell Survival; Clone Cells; Colony-Forming Units Assay; Cytarabine; Fluorouracil; Histidinol; Imidazoles; Leukemia L1210; Male; Mice; Mice, Inbred DBA | 1984 |
L-histidinol protection against cytotoxic action of cytosine arabinoside and 5-fluorouracil in cultured mouse spleen cells.
Topics: Animals; Cell Division; Cell Survival; Cells, Cultured; Cytarabine; Dose-Response Relationship, Drug; Fluorouracil; Histidinol; Imidazoles; Male; Mice; Mice, Inbred C57BL; Spleen; Time Factors | 1982 |